# Church & Dwight Co Inc: Form 10-Q for the period ended Mar 31, 2019

- Company: [Church & Dwight Co Inc](/companies/chd.md) (CIK 313927)
- Form: 10-Q
- Filed: 2019-05-02
- Accepted by EDGAR: May 2, 2019, 17:57 ET
- Period: 2019-03-31
- Accession: 0001564590-19-015199
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/313927/000156459019015199/chd-10q_20190331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/313927/000156459019015199/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-01-01 to 2019-03-31 | $1.04bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-01-01 to 2019-03-31 | $573.9m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2019-01-01 to 2019-03-31 | $470.8m | us-gaap:GrossProfit |
| Research and development | 3 months, 2019-01-01 to 2019-03-31 | $20.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2019-01-01 to 2019-03-31 | $131.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2019-01-01 to 2019-03-31 | $240.8m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-01-01 to 2019-03-31 | $17.8m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-01-01 to 2019-03-31 | $49.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-01-01 to 2019-03-31 | $175.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-01-01 to 2019-03-31 | $0.70 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-01-01 to 2019-03-31 | $0.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-01-01 to 2019-03-31 | 251,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2019-01-01 to 2019-03-31 | $137.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2019-01-01 to 2019-03-31 | $11.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2019-01-01 to 2019-03-31 | $55.9m | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months, 2019-01-01 to 2019-03-31 | $100.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2019-03-31 | $97.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-03-31 | $913.7m | us-gaap:AssetsCurrent |
| Total assets | at 2019-03-31 | $5.96bn | us-gaap:Assets |
| Current liabilities | at 2019-03-31 | $1.13bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-03-31 | $3.46bn | us-gaap:Liabilities |
| Long-term debt | at 2019-03-31 | $1.51bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2019-03-31 | $297.7m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | at 2019-03-31 | $99.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2019-03-31 | $2.50bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 19,653 characters.

#### Recent Developments

#### Flawless Acquisition

On May 1, 2019, we closed on our previously announced acquisition of the FLAWLESS™ and FINISHING TOUCH™ hair removal business (the “Flawless Acquisition”) from Ideavillage Products Corporation. We paid $475.0 at closing and will make an additional earn-out payment up to a maximum of $425.0 in cash, based on a trailing twelve-month net sales target ending no later than December 31, 2021. The transaction was funded with a three-year term loan and commercial paper borrowings. We anticipate there will be a four-month integration transition period in which the net cash received from Ideavillage will be accounted for as other revenue as a component of net sales. We will purchase the inventory following the transition period. FLAWLESS will be accounted for in the Consumer Domestic and Consumer International segments and represents an addition to our specialty haircare portfolio which includes BATISTE dry shampoo, VIVISCAL hair thinning supplements, and TOPPIK hair fibers.

#### Amended Credit Agreement

On May 1, 2019, we amended our $1,000.0 unsecured revolving credit facility (the “Credit Agreement”) to extend the term of the Credit Agreement from March 29, 2023 to March 29, 2024. Under the Credit Agreement, we continue to have the ability to increase our borrowing up to an additional $600.0, subject to lender commitments and certain conditions as described in the Credit Agreement. Borrowings under the Credit Agreement are available for general corporate purposes and are used to support our $1,000.0 commercial paper program.

#### New Term Loan

On May 1, 2019, we entered into a new $300.0 unsecured term loan credit facility with various banks, the proceeds of which were used to partially fund the Flawless Acquisition. Unless prepaid, the loan is due on May 1, 2022. The interest rate is LIBOR plus an applicable margin based on our credit rating, which can range from 60 bps to 113 bps.

### Results of Operations

### Consolidated results

|  | Three Months Ended March 31, 2019 | Change vs. Prior Year | Three Months Ended March 31, 2018 |
| --- | ---: | ---: | ---: |
| **Net Sales** | **$1,044.7** | 3.8% | $1,006.0 |
| **Gross Profit** | **$470.8** | 4.3% | $451.5 |
| Gross Margin | **45.1%** | +20 basis points | 44.9% |
| **Marketing Expenses** | **$98.1** | -1.8% | $99.9 |
| Percent of Net Sales | **9.4%** | -50 basis points | 9.9% |
| **Selling, General & Administrative Expenses** | **$131.9** | 0.5% | $131.3 |
| Percent of Net Sales | **12.6%** | -50 basis points | 13.1% |
| **Income from Operations** | **$240.8** | 9.3% | $220.3 |
| Operating Margin | **23.1%** | +120 basis points | 21.9% |
| **Net income per share - Diluted** | **$0.70** | 11.1% | $0.63 |

20

#### Net Sales

Net sales for the quarter ended March 31, 2019 were $1,044.7, an increase of $38.7 or 3.8% as compared to the same period in 2018. The components of the net sales increase are as follows:

| Net Sales - Consolidated | Three Months Ended March 31, 2019 |
| --- | ---: |
| Product volumes sold | 2.2% |
| Pricing/Product mix | 2.3% |
| Foreign exchange rate fluctuations | (1.0%) |
| Volume from acquired product lines (1) | 0.3% |
| **Net Sales increase** | **3.8%** |

(1) On March 8, 2018, we acquired Passport Food Safety Solutions, Inc. (“Passport”).

For the three months ended March 31, 2019, the volume change primarily reflects increased product sales in both the Consumer Domestic and Consumer International segments, with volume declines in Specialty Products. For the three months ended March 31, 2019, favorable price/mix in the Consumer Domestic and SPD segments were partially offset by unfavorable price/mix in the Consumer International segment.

#### Gross Profit / Gross Margin

Our gross profit was $470.8 for the three months ended March 31, 2019, a $19.3 increase as compared to the same period in 2018. Gross margin increased 20 basis points (“bps”) in the first quarter of 2019 compared to the same period in 2018, primarily due to productivity programs of 130 bps, and favorable price/volume mix of 70 bps, partially offset by higher commodity and transportation costs of 100 bps, and other manufacturing cost increases of 80 bps.

#### Operating Expenses

Marketing expenses for the three months ended March 31, 2019 were $98.1, a decrease of $1.8 or 1.8% as compared to the same period in 2018. Marketing expenses as a percentage of net sales in the first quarter of 2019 decreased by 50 bps to 9.4% as compared to 9.9% in the same period in 2018 due to 30 bps of leverage on higher net sales and 20 bps on lower expenses.

Selling, general and administrative (“SG&A”) expenses were $131.9 in the first quarter of 2019, an increase of $0.6 or 0.5% as compared to the same period in 2018. SG&A as a percentage of net sales decreased 50 bps to 12.6% in the first quarter of 2019 as compared to 13.1% in the same period in 2018. The decrease is due to 50 bps of leverage associated with higher sales.

#### Other Income and Expenses

Other expense, net for the three months ended March 31, 2019 decreased $2.0 compared to the same period in 2018 primarily due to the effect of changes in foreign exchange rates.

Interest expense for the three months ended March 31, 2019 decreased $2.3 as compared to the same period in 2018 primarily due to a lower amount of average debt outstanding primarily associated with repayment of the $300.0 Floating Rate Senior Notes that matured on January 25, 2019 and lower commercial paper borrowings in 2019 as compared to the same period in 2018.

#### Income Taxes

The effective tax rate for the three months ended March 31, 2019 was 21.9% compared to 21.4% in the same period in 2018. The increase in the tax rate is primarily due to a lower tax benefit on a lower amount of stock option exercises.

### Segment results

We operate three reportable segments: Consumer Domestic, Consumer International and SPD. These segments are determined based on differences in the nature of products and organizational and ownership structures. We also have a Corporate segment.

| Segment | Products |
| --- | --- |
| Consumer Domestic | Household and personal care products |
| Consumer International | Primarily personal care products |
| SPD | Specialty chemical products |

The Corporate segment income consists of equity in earnings of affiliates. As of March 31, 2019, we held 50% ownership interests in each of Armand Products Company (“Armand”) and The ArmaKleen Company (“ArmaKleen”), respectively. Our equity in earnings of Armand and ArmaKleen for the three months ended March 31, 2019 and 2018 are included in the Corporate segment. Certain subsidiaries that are included in the Consumer International segment manufacture and sell personal care products to the Consumer Domestic segment. These sales are eliminated from the Consumer International segment results set forth below.

Segment net sales and income before income taxes for the months ended March 31, 2019 and March 31, 2018 are as follows:

| Net Sales(1) | Consumer Domestic | Consumer International | SPD | Corporate | Total |
| --- | ---: | ---: | ---: | ---: | ---: |
| **First Quarter 2019** | **$784.9** | **$186.7** | **$73.1** | **$0.0** | **$1,044.7** |
| First Quarter 2018 | 751.4 | 180.7 | 73.9 | 0.0 | 1,006.0 |
| **Income before Income Taxes(2)** |  |  |  |  |  |
| **First Quarter 2019** | **$182.7** | **$28.4** | **$12.3** | **$1.7** | **$225.1** |
| First Quarter 2018 | 159.3 | 27.7 | 11.6 | 2.1 | 200.7 |

(1) Intersegment sales from Consumer International to Consumer Domestic, which are not reflected in the table, were $2.3 and $0.9 for the three months ended March 31, 2019 and March 31, 2018, respectively.

(2) In determining Income before Income Taxes, interest expense, investment earnings and certain aspects of other income and expense were allocated among the segments based upon each segment’s relative Income from Operations.

Product line revenues from external customers are as follows:

|  | Three Months Ended March 31, 2019 | March 31, 2018 |
| --- | ---: | ---: |
| Household Products | **$443.3** | $413.0 |
| Personal Care Products | **341.6** | 338.4 |
| Total Consumer Domestic | **784.9** | 751.4 |
| Total Consumer International | **186.7** | 180.7 |
| Total SPD | **73.1** | 73.9 |
| **Total Consolidated Net Sales** | **$1,044.7** | $1,006.0 |

Household Products include laundry, deodorizing, and cleaning products. Personal Care Products include condoms, pregnancy kits, oral care products, skin care and hair care products and gummy dietary supplements.

### Consumer Domestic

Consumer Domestic net sales in the first quarter of 2019 were $784.9, an increase of $33.5 or 4.5% as compared to the same period in 2018. The components of the net sales change are the following:

| Net Sales - Consumer Domestic | Three Months Ended March 31, 2019 |
| --- | ---: |
| Product volumes sold | 1.0% |
| Pricing/Product mix | 3.5% |
| **Net Sales increase** | **4.5%** |

The increase in net sales for the three months ended March 31, 2019, reflects higher sales of ARM & HAMMER liquid and unit dose laundry detergent, ARM & HAMMER clumping cat litter, TROJAN condoms, XTRA liquid laundry detergent, L’IL CRITTERS gummy vitamins, and BATISTE dry shampoo.

There continues to be significant product competition in the gummy vitamin category. The category has grown from eight competitors to 30 in the last five years. We continue to evaluate and vigorously combat these pressures through, among other things, new product introductions and increased marketing and trade spending. However, there is no assurance this category will not decline in the future and that we will be able to offset any such decline.

Consumer Domestic income before income taxes for the first quarter of 2019 was $182.7, a $23.4 increase as compared to the first quarter of 2018. The increase is due primarily to favorable price/mix of $18.9, lower marketing expenses of $4.2, lower interest and other expenses of $3.4, higher sales volumes of $1.4, lower SG&A costs of $1.0, partially offset by unfavorable manufacturing and distribution costs of $5.5.

### Consumer International

Consumer International net sales were $186.7 in the first quarter of 2019, an increase of $6.0 or 3.3% as compared to the same period in 2018. The components of the net sales change are the following:

| Net Sales - Consumer International | Three Months Ended March 31, 2019 |
| --- | ---: |
| Product volumes sold | 10.2% |
| Pricing/Product mix | (1.7%) |
| Foreign exchange rate fluctuations / Other | (5.2%) |
| **Net Sales increase** | **3.3%** |

Excluding the impact of foreign exchange rates, higher sales in the first quarter ended March 31, 2019 were primarily due to FEMFRESH, BATISTE, STERIMAR, and ARM & HAMMER liquid laundry detergent in the Global Market Group (formerly Export) business, ARM & HAMMER clumping cat litter and liquid laundry detergent in Canada, BATISTE in Germany, and WATERPIK in several countries.

Consumer International income before income taxes was $28.4 in the first quarter 2019, an increase of $0.7 compared to the same period in 2018 due primarily to higher sales volumes of $10.5, partially offset by higher costs as a result of the higher marketing expenses of $3.8, unfavorable manufacturing costs of $2.6, unfavorable price/mix of $1.6, unfavorable foreign exchange rates of $1.5, and higher SG&A costs of $1.1.

### Specialty Products (“SPD”)

SPD net sales were $73.1 in the first quarter of 2019, a decrease of $0.8 or 1.1% as compared to the same period in 2018. The components of the net sales change are the following:

| Net Sales - SPD | Three Months Ended March 31, 2019 |
| --- | ---: |
| Product volumes sold | (4.5%) |
| Pricing/Product mix | 0.3% |
| Volume from acquired product lines (1) | 3.1% |
| **Net Sales increase** | **(1.1%)** |

(1) Includes net sales of Passport since the date of acquisition.

Excluding the impact of the acquisitions, the net sales decrease in the first quarter of 2019 was driven by lower volumes in the animal and food production business, partially offset by higher broad-based pricing. Demand in the dairy industry is significantly reduced due to low milk prices.

SPD income before income taxes was $12.3 in the first quarter of 2019, an increase of $0.7 as compared to the same period in 2018 due to favorable manufacturing costs of $1.6, favorable price/product mix of $0.2 and lower marketing costs of $0.2, partially offset by higher SG&A costs of $1.1 and lower sales volumes of $0.4.

### Corporate

The Corporate segment includes equity in earnings of affiliates from Armand and ArmaKleen in the first quarter of 2019 and 2018. The Corporate segment income before income taxes was $1.7 in the first quarter of 2019, as compared to $2.1 in the same period in 2018.

### Liquidity and Capital Resources

On May 1, 2019, we amended our $1,000.0 unsecured revolving credit facility (the “Credit Agreement”) to extend the term of the Credit Agreement from March 29, 2023 to March 29, 2024. Under the Credit Agreement, we continue to have the ability to increase our borrowing up to an additional $600.0, subject to lender commitments and certain conditions as described in the Credit Agreement. Borrowings under the Credit Agreement are available for general corporate purposes and are used to support our $1,000.0 commercial paper program.

On May 1, 2019, we entered into a new $300.0 unsecured term loan credit facility with various banks, the proceeds of which were used to partially fund the Flawless Acquisition. Unless prepaid, the loan is due on May 1, 2022. The interest rate is LIBOR plus an applicable margin based on our credit rating, which can range from 60 bps to 113 bps.

As of March 31, 2019, we had $97.9 in cash and cash equivalents, and approximately $899.0 available through the revolving facility under our Credit Agreement and our commercial paper program. To preserve our liquidity, we invest cash primarily in government money market funds, prime money market funds, short-term commercial paper and short-term bank deposits.

We repatriate excess cash held at our foreign subsidiaries. We repatriated approximately $16.0 million during the first quarter of 2019 and anticipate an additional $20.0 million during the balance of 2019. As of March 31, 2019, there is $45.0 million of cash and cash equivalents held at foreign subsidiaries.

The current economic environment presents risks that could have adverse consequences for our liquidity. See “Unfavorable economic conditions could adversely affect demand for our products” under “Risk Factors” in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (the “Form 10-K”). We do not anticipate that current economic conditions will adversely affect our ability to comply with the financial covenant in the Credit Agreement because we currently are, and anticipate that we will continue to be, in compliance with the maximum leverage ratio requirement under the Credit Agreement.

On February 5, 2019, the Board declared a 5% increase in the regular quarterly dividend from $0.2175 to $0.2275 per share, equivalent to an annual dividend of $0.91 per share. The increase raises the annual dividend payout from $213.3 to approximately $225.0.

In connection with the evergreen repurchase program, in January 2019, we executed open market purchases of $100.0 of our Common Stock. See Part II – Item 2 of this Form 10Q for further details.

We anticipate that our cash from operations, together with our current borrowing capacity, will be sufficient to meet our capital expenditure program costs, which are expected to be approximately $85.0 in 2019, fund our share repurchase programs to the extent implemented by management, pay the upcoming maturing notes and pay dividends at the latest approved rate. Cash, together with our current borrowing capacity, may be used for acquisitions that would complement our existing product lines or geographic markets. We did not have any mandatory fixed rate debt principal payments in 2018. We paid the $300.0 Floating Rate Senior Notes that matured on January 25, 2019 with cash on hand and commercial paper. The $300.0 Senior Notes (2.45%) will mature on December 15, 2019 and we currently intend to repay these notes with cash on hand and commercial paper borrowing if necessary.

#### Cash Flow Analysis

|  | Three Months Ended March 31, 2019 | March 31, 2018 |
| --- | ---: | ---: |
| Net cash provided by operating activities | **$137.9** | $155.5 |
| Net cash used in investing activities | **$(12.4)** | $(60.0) |
| Net cash used in financing activities | **$(344.3)** | $(255.6) |

**Net Cash Provided by Operating Activities –** Our primary source of liquidity is the cash flow provided by operating activities, which is dependent on net income and changes in working capital. Our net cash provided by operating activities in the three months ended March 31, 2019 decreased by $17.6 to $137.9 as compared to $155.5 in the same period in 2018 due to higher cash earnings (net income plus non-cash expenses such as depreciation, amortization, and non-cash compensation) more than offset by an increase in working capital. The change in working capital is primarily due to an increase in accounts receivable due to the timing of sales and a decrease in accounts payable and accrued expenses due to higher incentive compensation and profit sharing payments partially offset by our continued program to extend payment terms with our suppliers. However, we measure working capital effectiveness based on our cash conversion cycle. The following table presents our cash conversion cycle information for the quarters ended March 31, 2019 and 2018:

|  | As of March 31, 2019 | March 31, 2018 | Change |
| --- | ---: | ---: | ---: |
| Days of sales outstanding in accounts receivable ("DSO") | 31 | 31 | 0 |
| Days of inventory outstanding ("DIO") | 61 | 56 | 5 |
| Days of accounts payable outstanding ("DPO") | 67 | 65 | (2) |
| Cash conversion cycle | 25 | 22 | 3 |

Our cash conversion cycle (defined as the sum of DSO and DIO less DPO) which is calculated using a two period average method, increased three days from the prior year amount of 22 days to 25 days at March 31, 2019 due primarily to an increase in DIO of 5 days. DPO increased two days from 65 to 67 days and DSO remained consistent compared to the same period in 2018. The increase in the cash conversion cycle is primarily due to certain acquisitions, which currently require a higher level of working capital. We continue to focus on reducing our working capital requirements.

**Net Cash Used in Investing Activities –** Net cash used in investing activities during the first three months of 2019 was $12.4, primarily reflecting $11.7 for property, plant and equipment additions. Net cash used in investing activities during the first three months of 2018 was 60.0, primarily reflecting $49.9 for the Passport Acquisition, and $9.9 for property, plant and equipment additions.

**Net Cash Used in Financing Activities –** Net cash used in financing activities during the first three months of 2019 was $344.3, reflecting $202.0 of net debt payments, $100.0 of repurchases of our common stock (“Common Stock”), $55.9 of cash dividend payments, partially offset by $15.1 of proceeds from stock option exercises. Net cash used in financing activities during the first three months of 2018 was $255.6, reflecting $200.0 of repurchases of our Common Stock, $53.0 of cash dividend payments, $17.4 of debt payments, partially offset by $16.4 of proceeds from stock option exercises.

## Market risk

As filed, 282 characters.

### Market risk

For quantitative and qualitative disclosures about market risk affecting the Company, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 7A of Part II the Form 10-K. Our exposure to market risk has not changed materially since December 31, 2018.

## Controls and procedures

As filed, 5,902 characters.

a) Evaluation of Disclosure Controls and Procedures

The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) at the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures, as of the end of the period covered by this report, are effective to provide reasonable assurance that the information required to be disclosed by the Company in reports filed under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the rules and forms of the United States Securities and Exchange Commission (the “Commission”), and (ii) accumulated and communicated to the Company’s management, including the Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding the disclosure.

b) Change in Internal Control over Financial Reporting

There were no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurring during the Company’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

### CAUTIONARY NOTE ON FORWARD-LOOKING INFORMATION

This report contains forward-looking statements, including, among others, statements relating to net sales and earnings growth; gross margin changes; trade and marketing spending; marketing expense as a percentage of net sales; sufficiency of cash flows from operations; earnings per share; the impact of new accounting pronouncements; cost savings programs; consumer demand and spending; the effects of competition; the effect of product mix; volume growth, including the effects of new product launches into new and existing categories; the increase in the number of gummy dietary supplement competitors; the Company’s hedge programs; the impact of foreign exchange, tariffs, and commodity price fluctuations; impairments and other charges; the Company’s investments in joint ventures; the impact of acquisitions and divestitures; capital expenditures; the Company’s effective tax rate; the impact of the Tax Cuts and Jobs Act; the impact of tax audits; tax changes and the lapse of applicable statutes of limitations; the effect of the credit environment on the Company’s liquidity and capital resources; the Company’s fixed rate debt; compliance with covenants under the Company’s debt instruments; the Company’s commercial paper program; the Company’s current and anticipated future borrowing capacity to meet capital expenditure program costs; and the Company’s share repurchase programs; payment of dividends; environmental and regulatory matters; the availability and adequacy of raw materials, including trona reserves and the conversion of such reserves; and the customers and consumer acceptance of certain ingredients in our products. These statements represent the intentions, plans, expectations and beliefs of the Company, and are based on assumptions that the Company believes are reasonable but may prove to be incorrect. In addition, these statements are subject to risks, uncertainties and other factors, many of which are outside the Company’s control and could cause actual results to differ materially from such forward-looking statements. Factors that could cause such differences include a decline in market growth, retailer distribution and consumer demand (as a result of, among other things, political, economic and marketplace conditions and events); unanticipated increases in raw material and energy prices; delays or other problems in manufacturing or distribution; adverse developments affecting the financial condition of major customers and suppliers; competition; changes in marketing and promotional spending; growth or declines in various product categories and the impact of customer actions in response to changes in consumer demand and the economy, including increasing shelf space of private label products; consumer and competitor reaction to, and customer acceptance of, new product introductions and features; the Company’s ability to maintain product quality and characteristics at a level acceptable to our customers and consumers; disruptions in the banking system and financial markets; foreign currency exchange rate fluctuations; implications of the United Kingdom’s withdrawal from the European Union; shifting economic policies in the United States; potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs, including the actual and potential effect of tariffs on Chinese goods imposed by the United States; issues relating to the Company’s information technology and controls; the impact of natural disasters on the Company and its customers and suppliers, including third party information technology service providers; the acquisition or divestiture of assets; the outcome of contingencies, including litigation, pending regulatory proceedings and environmental matters; and changes in the regulatory environment.

The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by the United States federal securities laws. You are advised, however, to consult any further disclosures the Company makes on related subjects in its filings with the United States Securities and Exchange Commission (the “Commission”).

## Risk factors

As filed, 252 characters.

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Form 10-K, which could materially affect the Company’s business, financial condition or future results.

Filed May 2, 2019.
Source: SEC EDGAR, the filing index for accession 0001564590-19-015199. Last ingested by Listed: Nov 14, 2026, 21:34 ET. No prices; not investment advice.
